Literature DB >> 8549691

The human lacrimal gland synthesizes apolipoprotein D mRNA in addition to tear prealbumin mRNA, both species encoding members of the lipocalin superfamily.

P Holzfeind1, P Merschak, H Dieplinger, B Redl.   

Abstract

Apolipoprotein D (apoD), a glycoprotein originally characterized as a component of the high density lipoprotein fraction of human plasma and known to be a member of the lipocalin protein superfamily, has been found in human tear fluid by Western blot analysis. Unlike serum it seems that in the tear fluid apoD exists mainly as a disulphide linked homodimer which is not associated with lecithin/cholesterol acyltransferase (LCAT) or apolipoprotein A-I (apo A-I). By reverse-transcription-PCR (RT-PCR) of mRNA extracted from a human lacrimal gland and use of specific primers we could demonstrate expression of the apoD gene in this tissue. The amplified cDNA was cloned and a subsequent sequence analysis confirmed the identity of apoD mRNA in the human lacrimal gland. These investigations indicate that the lacrimal gland is the site of synthesis of the tear fluid apoD. Although the physiological function of apoD is unknown, it has the ability to bind phospholipids, cholesterol and other small hydrophobic molecules. Therefore, this protein might interact with meibomian lipids present in human tear fluid and probably contribute to the surface spreading of these lipids or it may function as a clearance factor, protecting the cornea from harmful lipophilic molecules.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549691     DOI: 10.1016/s0014-4835(05)80145-9

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  9 in total

Review 1.  Apolipoprotein D.

Authors:  Eric Rassart; Frederik Desmarais; Ouafa Najyb; Karl-F Bergeron; Catherine Mounier
Journal:  Gene       Date:  2020-06-15       Impact factor: 3.688

Review 2.  The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease.

Authors:  Kari B Green-Church; Igor Butovich; Mark Willcox; Douglas Borchman; Friedrich Paulsen; Stefano Barabino; Ben J Glasgow
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 3.  The lipocalin protein family: structure and function.

Authors:  D R Flower
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

Review 4.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

5.  Single eye analysis and contralateral eye comparison of tear proteins in normal and dry eye model rabbits by MALDI-ToF mass spectrometry using wax-coated target plates.

Authors:  Bryan M Ham; Jean T Jacob; Richard B Cole
Journal:  Anal Bioanal Chem       Date:  2007-01-09       Impact factor: 4.142

6.  Albumin as a tear supplement in the treatment of severe dry eye.

Authors:  S Shimmura; R Ueno; Y Matsumoto; E Goto; A Higuchi; J Shimazaki; K Tsubota
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

7.  Interaction of ceramides and tear lipocalin.

Authors:  Ben J Glasgow; Adil R Abduragimov
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-01-11       Impact factor: 4.698

8.  LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea.

Authors:  Rhonda Flores; Xueting Jin; Janet Chang; Connie Zhang; David G Cogan; Ernst J Schaefer; Howard S Kruth
Journal:  Biomolecules       Date:  2019-11-26

9.  Tear Lipocalin and Lipocalin-Interacting Membrane Receptor.

Authors:  Ben J Glasgow
Journal:  Front Physiol       Date:  2021-08-19       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.